Steroid-responsive nephrotic syndrome with minimal-change disease and IgA deposits in a HIV-infected patient.
Boix
E
E
Servicio de Nefrología, Hospital General Universitario de Alicante and Departamento de Medicina Clínica, Facultad de Medicina, Universidad Miguel Hernandez, Elche, Spain.
Rivera
F
F
Gil
C M
CM
Pérez-Contreras
J
J
Olivares
J
J
D019380:Anti-HIV Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D005920:Glomerular Mesangium / Q000378:metabolism; D005938:Glucocorticoids / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007070:Immunoglobulin A / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009402:Nephrosis, Lipoid / Q000150:complications*; D009404:Nephrotic Syndrome / Q000150:complications* / Q000188:drug therapy* / Q000378:metabolism; D011241:Prednisone / Q000627:therapeutic use*; D012008:Recurrence
D019380:Anti-HIV Agents; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D005938:Glucocorticoids; D007070:Immunoglobulin A; D011241:Prednisone